RDIF told about new article by The Lancet about "Sputnik Light"

“RDIF announces the publication of N.N.

N.F.

Gamalei in the leading peer-reviewed medical journal The Lancet, a study of a single-component vaccine against coronavirus Sputnik Light, according to which the drug demonstrated high safety and the formation of strong humoral and cellular immunity, "RIA Novosti said.

Earlier, the RDIF announced the high efficiency of Sputnik V in protecting the elderly from COVID-19.

In October, the foundation reported that the combination of the Russian Sputnik Light coronavirus vaccine with other vaccines after 14 days gives a greater immune response than using one vaccine.